14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
KRKR vs ZEPP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, 36Kr Holdings Inc. (KRKR) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). KRKR carries a Unified Composite Score of 45.3/100 (HOLD) at $2.56 (3.4x Forward P/E, 14.8% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin).
Technical & Structure Timing Caution: KRKR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KRKR vs ZEPP. Trailing 12-month operating profitability (KRKR 14.8% vs ZEPP -12.6%) and valuation multiples (KRKR 3.4x vs ZEPP 3.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consumer Electronics value chain with $37.0M market capitalization and -12.6% operating margin.
OpEx & R&D Reinvestment51.2% of Rev ($141M)
90D Engineering Disclosures0 Published
Investor FAQ KRKR vs ZEPP Key Questions & Quantitative Answers
As of Nov 20, 2026, 36Kr Holdings Inc. (KRKR) is the stronger overall head-to-head candidate over Zepp Health Corporation (ZEPP) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). KRKR carries a Unified Composite Score of 45.3/100 (HOLD) at $2.56 (3.4x Forward P/E, 14.8% operating margin), whereas ZEPP carries 45.7/100 (HOLD) at $2.31 (3.1x Forward P/E, -12.6% operating margin). Technical & Structure Timing Caution: KRKR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0); meanwhile ZEPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
KRKR leads the Growth & Scale pillar: KRKR posts +33.7% YoY revenue growth and +0.0% YoY earnings growth on $1.8M TTM revenue (63.0% gross margin, 14.8% operating margin), compared with ZEPP at +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin). On trailing 12-month operating scale, KRKR generates $1.8M in USD-normalized revenue versus $276M for ZEPP. In operating R&D and SG&A reinvestment, KRKR deploys 48.2% of Rev ($872,095) (0 90-day corporate R&D disclosures) versus 51.2% of Rev ($141M) (0 disclosures) for ZEPP.
ZEPP screens cheaper on headline valuation multiples. KRKR trades at 3.4x Forward P/E, 24.1x Trailing P/E, N/M PEG, and 2.9x EV/Revenue (15.5% EBITDA margin), whereas ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KRKR (24.6% ROE) versus ZEPP (-21.2% ROE) capital efficiency.
In options market volatility and institutional positioning, KRKR carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 47% Vol realized risk). By comparison, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.